» Articles » PMID: 37532176

The Hyperproliferation Mechanism of Cholesteatoma Based on Proteomics: SNCA Promotes Autophagy-Mediated Cell Proliferation Through the PI3K/AKT/CyclinD1 Signaling Pathway

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Cholesteatoma is a chronic inflammatory ear disease with abnormal keratinized epithelium proliferation and tissue damage. However, the mechanism of keratinized epithelium hyperproliferation in cholesteatoma remains unknown. Hence, our study sought to shed light on mechanisms affecting the pathology and development of cholesteatoma, which could help develop adjunctive treatments. To investigate molecular changes in cholesteatoma pathogenesis, we analyzed clinical cholesteatoma specimens and paired ear canal skin with mass spectrometry-based proteomics and bioinformatics. From our screen, alpha-synuclein (SNCA) was overexpressed in middle ear cholesteatoma and might be a key hub protein associated with inflammation, proliferation, and autophagy in cholesteatoma. SNCA was more sensitive to lipopolysaccharide-induced inflammation, and autophagy marker increase was accompanied by autophagy activation in middle ear cholesteatoma tissues. Overexpression of SNCA activated autophagy and promoted cell proliferation and migration, especially under lipopolysaccharide inflammatory stimulation. Moreover, inhibiting autophagy impaired SNCA-mediated keratinocyte proliferation and corresponded with inhibition of the PI3K/AKT/CyclinD1 pathways. Also, 740Y-P, a PI3K activator reversed the suppression of autophagy and PI3K signaling by siATG5 in SNCA-overexpressing cells, which restored proliferative activity. Besides, knockdown of SNCA in RHEK-1 and HaCaT cells or knockdown of PI3K in RHEK-1 and HaCaT cells overexpressing SNCA both resulted in attenuated cell proliferation. Our studies indicated that SNCA overexpression in cholesteatoma might maintain the proliferative ability of cholesteatoma keratinocytes by promoting autophagy under inflammatory conditions. This suggests that dual inhibition of SNCA and autophagy may be a promising new target for treating cholesteatoma.

Citing Articles

The role of S100A8 and S100A9 in external auditory canal cholesteatoma.

He G, Han W, Zhu Z, Wei R, Lin C Front Immunol. 2024; 15:1457163.

PMID: 39575241 PMC: 11578731. DOI: 10.3389/fimmu.2024.1457163.


Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer.

Wu Z, Xiang H, Wang X, Zhang R, Guo Y, Qu L Mol Med. 2024; 30(1):166.

PMID: 39342122 PMC: 11439318. DOI: 10.1186/s10020-024-00928-2.


LGR5 Modulates Differentiated Phenotypes of Chondrocytes Through PI3K/AKT Signaling Pathway.

Wu X, Fu Y, Ma J, Li C, He A, Zhang T Tissue Eng Regen Med. 2024; 21(5):791-807.

PMID: 38771465 PMC: 11187034. DOI: 10.1007/s13770-024-00645-1.


Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.

Zeng L, Xie L, Hu J, He C, Liu A, Lu X Cell Cycle. 2024; 23(5):537-554.

PMID: 38662954 PMC: 11135870. DOI: 10.1080/15384101.2024.2345481.


OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy.

Zhou R, Li R, Ding Q, Zhang Y, Yang H, Han Y Sci Rep. 2024; 14(1):8670.

PMID: 38622371 PMC: 11018812. DOI: 10.1038/s41598-024-59367-y.

References
1.
Ouyang W, Li J, Zhang D, Jiang B, Huang D . PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1. J Cell Biochem. 2007; 101(4):969-78. DOI: 10.1002/jcb.21279. View

2.
Rodriguez-Araujo G, Nakagami H, Hayashi H, Mori M, Shiuchi T, Minokoshi Y . Alpha-synuclein elicits glucose uptake and utilization in adipocytes through the Gab1/PI3K/Akt transduction pathway. Cell Mol Life Sci. 2012; 70(6):1123-33. PMC: 11113429. DOI: 10.1007/s00018-012-1198-8. View

3.
Xie S, Xiang Y, Wang X, Ren H, Yin T, Ren J . Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways. Laryngoscope. 2016; 126(8):1923-30. DOI: 10.1002/lary.25834. View

4.
Li Y, Wang X, Wang X, Wan L, Liu Y, Shi Y . PDCD4 suppresses proliferation, migration, and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway. Biol Reprod. 2018; 99(2):360-372. DOI: 10.1093/biolre/ioy052. View

5.
Yan P, Venkataramu C, Ibrahim A, Liu J, Shen R, Diaz N . Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res. 2006; 12(22):6626-36. DOI: 10.1158/1078-0432.CCR-06-0467. View